GlassScriptPhysician profile
William Guillermo Cano
NPI 1730103177
$6,154.42
in general payments reported to CMS, 2019-2025
35 companies · $500 in 2025
The $500 reported for 2025 was more than what 79% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,340 · 2020: $399 · 2021: $2,381 · 2022: $548 · 2023: $419 · 2024: $567 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,447 · Debt Forgiveness: $38.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,447.02 |
| Debt Forgiveness | $38.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $1,924.94 | 2019-2024 | Mild Device Kit |
| Nevro Corp. | $1,297.55 | 2019-2024 | Senza |
| Scilex Pharmaceuticals INC. | $714.50 | 2019-2025 | Ztlido |
| Boston Scientific Corporation | $418.37 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept Rf Probe |
| Zyla Life Sciences, INC. | $352.71 | 2019-2020 | |
| Abbott Laboratories | $167.31 | 2019-2022 | |
| Painteq LLC | $118.11 | 2023-2024 | Painteq |
| Medtronic, INC. | $98.54 | 2025 | Inceptiv |
| Nalu Medical, INC. | $98.06 | 2021-2023 | Nalu Neurostimulation System |
| Pfizer INC. | $88.36 | 2019-2023 | |
| Foundation Fusion Solutions, LLC | $86.43 | 2021-2025 | |
| Electronic Waveform Lab, INC. | $75.04 | 2019-2024 | |
| Globus Medical, INC. | $70.58 | 2025 | Senza |
| Vertical Pharmaceuticals, LLC | $59.92 | 2019 | |
| Tersera Therapeutics LLC | $56.82 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $52.86 | 2020-2022 | |
| Biotronik Nro, INC. | $39.28 | 2024-2025 | Prospera |
| Baxter Healthcare | $38.71 | 2023 | |
| Appliedvr INC | $38.02 | 2025 | Relievrx |
| Abbvie INC. | $33.87 | 2023 | Ubrelvy, Qulipta |
| Vertex Pharmaceuticals Incorporated | $32.31 | 2024-2025 | |
| Medtronic USA, INC. | $32.06 | 2019 | |
| Spr Therapeutics, INC | $29.77 | 2024 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $29.44 | 2021 | |
| Si-Bone, INC. | $26.50 | 2022 | |
| Bioventus LLC | $26.19 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.71 | 2023 | Zilretta, Iovera |
| Amneal Pharmaceuticals LLC | $20.01 | 2023 | Lyvispah |
| Averitas Pharma INC. | $19.08 | 2023 | Qutenza |
| Orthogenrx INC. | $18.75 | 2021 | |
| Collegium Pharmaceutical, INC. | $18.66 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.92 | 2022 | |
| Eisai INC. | $12.65 | 2020 | |
| Allergan, INC. | $12.36 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.